Financial comparisons Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 55.89 USD | -1.60% |
|
-4.05% | +26.88% |
| 08-21 | Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says | MT |
| 08-21 | Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | - | - | - | -123.08% | -85.97% | 0.58x | |
| 6.5B | 42.13% | 52.64% | 28.56% | 20.88% | -0.99x | |
| 4.25B | 30.41% | 24.81% | 20.15% | 17.36% | -3.18x | |
| 606M | -210.54% | -205.59% | -249.28% | - | 0.72x | |
| 3.37B | -39.59% | -48.95% | -5.88% | -5.1% | 6.99x | |
| 3.69B | 25.89% | 28.63% | 17.53% | 9.99% | -1.51x | |
| 498M | 32.27% | 31.52% | 16.97% | 14.74% | -3.83x | |
| 294M | -18.56% | -24.05% | -9.34% | -9.05% | 8.22x | |
| 2.32B | 33.73% | 37.59% | 35.53% | 27.02% | -1.18x | |
| 958M | -30.08% | -31.31% | -42.49% | - | 2.15x | |
| 829M | -0.2% | 11.86% | -0.5% | - | -6.61x | |
| 88.04M | -891.6% | -695.44% | - | -55.55% | 0.05x | |
| 113M | -310.18% | -226% | - | - | - | |
| 742M | 42.2% | 49.8% | 35.4% | 31.62% | - | |
| 1.16B | 23.46% | 22.49% | 20.46% | 11.16% | 0.73x | |
| 1.81B | 2.28% | 8.85% | 1.39% | 0.63% | 3.17x | |
| Average | 1.81B | -84.56% | -64.21% | -18.18% | -1.86% | 0.38x | |
| Weighted average by Cap. | 3.14B | -37.7% | -27.73% | -11.53% | 8.71% | -0.27x |
- Stock Market
- Stocks
- SRRK Stock
- Sector Scholar Rock Holding Corporation
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
